# Safety of and Immune Response to Vaccination With 2 Experimental HIV Vaccines in Healthy Adults

> **NCT02109354** · PHASE1 · COMPLETED · sponsor: **HIV Vaccine Trials Network** · enrollment: 202 (actual)

## Conditions studied

- HIV Infection

## Interventions

- **BIOLOGICAL:** ALVAC-HIV
- **BIOLOGICAL:** AIDSVAX B/E
- **BIOLOGICAL:** Placebo for ALVAC-HIV
- **BIOLOGICAL:** Placebo for AIDSVAX B/E
- **BIOLOGICAL:** Hepatitis B vaccine
- **BIOLOGICAL:** Tetanus toxoid vaccine
- **BIOLOGICAL:** Placebo for hepatitis B vaccine
- **BIOLOGICAL:** Placebo for tetanus vaccine

## Key facts

- **NCT ID:** NCT02109354
- **Lead sponsor:** HIV Vaccine Trials Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06-18
- **Primary completion:** 2015-02-02
- **Final completion:** 2015-02-02
- **Target enrollment:** 202 (ACTUAL)
- **Last updated:** 2019-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02109354

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02109354, "Safety of and Immune Response to Vaccination With 2 Experimental HIV Vaccines in Healthy Adults". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02109354. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*